Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 05 Sep 2023 – 20 Aug 2026, limited by Navi BSE Sensex Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Navi BSE Sensex Index Fund | Nifty 50 |
|---|---|---|
| 05 Sep 2023 | ₹100.00 | ₹100.00 |
| 04 Dec 2023 | ₹104.56 | ₹105.68 |
| 03 Mar 2024 | ₹111.85 | ₹114.12 |
| 01 Jun 2024 | ₹112.26 | ₹115.10 |
| 30 Aug 2024 | ₹125.30 | ₹128.92 |
| 28 Nov 2024 | ₹120.21 | ₹122.17 |
| 26 Feb 2025 | ₹113.43 | ₹115.19 |
| 27 May 2025 | ₹123.76 | ₹126.83 |
| 25 Aug 2025 | ₹124.45 | ₹127.55 |
| 23 Nov 2025 | ₹129.86 | ₹133.17 |
| 21 Feb 2026 | ₹126.26 | ₹130.63 |
| 22 May 2026 | ₹114.90 | ₹121.17 |
| 20 Aug 2026 | ₹118.53 | ₹123.79 |
| Metric | Navi · Regular NAV ₹11.86 Very High risk ★☆☆☆☆ | Category median Index Funds · 366 funds |
|---|---|---|
| -5.03% | +5.43% | |
| +5.92% | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +5.92% | +7.40% | |
| +0.70% | — | |
| — | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 13.26% | 13.88% | |
| -0.04 | 0.25 | |
| -0.06 | 0.35 | |
| -16.22% | -16.66% | |
| Nifty 50 | — | |
| -1.38% | +0.30% | |
| 0.98 | 1.00 | |
| 97.0% | 101.3% | |
| 105.2% | 98.8% | |
| 1.08% | 0.96% | |
| ₹19.42Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 18% | 35% | |
| Ashutosh Shirwaikar | — | |
| 05 Sep 2023 | — | |
| 30 | — | |
| 64.3% | — | |
| 0.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.